Molecular Targeting Technologies, Inc.

MTTI is a privately held biotechnology company focused on the development of diagnostic and therapeutic molecules to address the unmet medical needs in cancer and cardiovascular diseases.

MTTI is also building a research reagents business and manufactures and sells an ever expanding portfolio of products, primarily based upon fluorescence, to meet the needs of cutting edge academic researchers.